Hospital
Clifton Springs Sanitarium Co
Clifton Springs Sanitarium Co was paid $1.80M by Medicaid between Apr 2018 and Nov 2024, across 48 billing codes. Its largest line is 90791, psychiatric diagnostic evaluation — 42% of everything it billed.
33Billing provider infoCLIFTON SPRINGS SANITARIUM CO
CLIFTON SPRINGS, NY 14432
CLIFTON SPRINGS, NY 14432
33aNPI1518021310assigned 12/19/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$1.80M
24GClaims22,721
24DCodes billed48
24AFirst – last monthApr 2018 – Nov 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in New York
Rank by total paid#12 of 33
Median peer was paid$171K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TINCH, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45 | $4K | |
| 2019 | 694 | $42K | |
| 2020 | 2,889 | $158K | |
| 2021 | 4,219 | $346K | |
| 2022 | 5,969 | $450K | |
| 2023 | 5,561 | $436K | |
| 2024incomplete | 3,344 | $367K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 42% | 1,382 | 1,165 | $758K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 1,918 | 1,755 | $237K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 1,698 | 1,584 | $201K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 9.4% | 1,772 | 1,249 | $169K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 8.5% | 1,162 | 733 | $153K |
| 36415 | Collection of venous blood by venipuncture | 2.5% | 2,081 | 1,820 | $44K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.3% | 302 | 271 | $41K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 487 | 438 | $35K |
| 80053 | Comprehensive metabolic panel | 1.8% | 2,318 | 2,170 | $32K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,150 | 1,006 | $18K |
| S9485 | Crisis intervention mental health services, per diem | <1% | 15 | 14 | $17K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 291 | 281 | $16K |
36 more codes
| 99285 | Emergency room visit (most serious) | <1% | 110 | $13K |
| 99284 | Emergency room visit (serious) | <1% | 85 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,471 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 234 | $6K |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 90 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 618 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 234 | $5K |
| 80061 | Lipid panel | <1% | 740 | $4K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 78 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 30 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,359 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 209 | $3K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 17 | $3K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 13 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 64 | $2K |
| 87660 | <1% | 99 | $799.35 | |
| 85027 | <1% | 263 | $788.82 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 12 | $613.51 |
| 87631 | <1% | 14 | $599.61 | |
| 82607 | <1% | 56 | $572.18 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 127 | $411.57 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 480 | $329.92 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 32 | $281.70 |
| 84702 | <1% | 111 | $210.77 | |
| 84439 | <1% | 28 | $207.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $168.03 |
| 81001 | <1% | 148 | $149.67 | |
| 83735 | <1% | 41 | $89.27 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 13 | $66.50 |
| 81025 | <1% | 28 | $66.10 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $33.33 |
| 83690 | <1% | 53 | $5.81 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 111 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 54 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 31 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 67 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTINCH, PAULA (SVP, FINANCE)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.